Your session is about to expire
← Back to Search
Ultrasound Therapy
LIFU for Cocaine Use Disorder
N/A
Recruiting
Led By Nassima Ait-Daoud Tiouririne, MD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Study Summary
This trial will test if Low-Intensity Focused Ultrasound (LIFU) can reduce cravings for cocaine. 60 people with Cocaine Use Disorder (CUD) will be screened and 30 will be enrolled to see the effects of LIFU on craving.
Who is the study for?
This trial is for adults over 18 with a recent diagnosis of cocaine use disorder, who can lie still for imaging tests, have reliable transport, and stable housing. They must be able to avoid cocaine at certain times during the study and meet criteria for MRI scans.Check my eligibility
What is being tested?
The study is testing Low-Intensity Focused Ultrasound (LIFU) against a sham device to see if it reduces cravings in people with Cocaine Use Disorder by looking at brain activity and subjective craving levels after exposure to cocaine cues.See study design
What are the potential side effects?
Since this trial involves non-invasive ultrasound technology, side effects are expected to be minimal. However, participants may experience discomfort or mild headaches from lying down during the procedure or from the sham device.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Decrease in average craving score by 25% for LIFU compared to sham
No evidence of neurological or other adverse events related to LIFU
Percent reduction in Bold Oxygen Level Dependent (BOLD)% signal change in response to cocaine cue exposure
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Low-Intensity Focused Ultrasound (LIFU)Experimental Treatment1 Intervention
All subjects to receive LIFU and Sham in a randomized order.
Group II: Sham LIFUPlacebo Group1 Intervention
All subjects to receive LIFU and Sham in a randomized order.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low-Intensity Focused Ultrasound
2020
N/A
~10
Find a Location
Who is running the clinical trial?
University of VirginiaLead Sponsor
754 Previous Clinical Trials
1,245,043 Total Patients Enrolled
Nassima Ait-Daoud Tiouririne, MDPrincipal InvestigatorUniversity of Virginia, Center for Leading Edge Addiction Research
1 Previous Clinical Trials
294 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can lie down for a long time for scans.I am willing and able to follow the study's schedule and procedures.I have a way to get to all my appointments during the study.I am 18 or older and have a history of cocaine use disorder.
Research Study Groups:
This trial has the following groups:- Group 1: Low-Intensity Focused Ultrasound (LIFU)
- Group 2: Sham LIFU
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor still enrolling participants?
"Clinicaltrials.gov reveals that recruitment for this research endeavour is in progress, which was first offered on March 1st 2023 and underwent a recent update on May 4th 2023."
Answered by AI
How many participants are partaking in this medical study?
"Affirmative. Based on the information published on clinicaltrials.gov, this study is actively seeking out participants and was recently updated on May 4th 2023- it started recruiting from March 1st of that year. The trial desires 30 patients to be recruited from a single site."
Answered by AI
Share this study with friends
Copy Link
Messenger